These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15339768)

  • 1. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
    Niemann I; Petersen LK; Hansen ES; Sunde L
    Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
    J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2006 Mar; 107(3):743. PubMed ID: 16507954
    [No Abstract]   [Full Text] [Related]  

  • 14. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of women with recurrent molar pregnancies.
    Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical issues in the management of low-risk gestational trophoblast tumors.
    Savage P; Seckl M; Short D
    J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.